Gilead Sciences Inc Stock
Price
Target price
€104.12
€104.12
0.750%
0.78
0.750%
€119.32
09.01.26 / Tradegate
WKN: 885823 / Symbol: GILD / Name: Gilead Sciences / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Gilead Sciences Inc Stock
The Gilead Sciences Inc stock is trending slightly upwards today, with an increase of €0.78 (0.750%) compared to yesterday's price.
With 40 Buy predictions and not a single Sell prediction Gilead Sciences Inc is an absolute favorite of our community.
As a result the target price of 119 € shows a slightly positive potential of 14.29% compared to the current price of 104.12 € for Gilead Sciences Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Gilead Sciences Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Gilead Sciences Inc in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Gilead Sciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | 0.750% | 0.328% | 1.402% | 20.999% | -1.792% | 31.315% | 101.939% |
| Incyte Corp. | 1.300% | 6.051% | 12.219% | 29.535% | 9.048% | 25.054% | 19.692% |
| Regeneron Pharmaceuticals Inc. | -0.760% | 3.320% | 14.904% | -4.010% | 3.227% | 7.862% | 67.774% |
| Amgen Inc. | -1.540% | 0.215% | 3.834% | 9.172% | 0.054% | 11.341% | 43.699% |
Comments
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Citigroup Inc. from $135.00 to $140.00. They now have a "buy" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at UBS Group AG. They now have a $145.00 price target on the stock, up previously from $112.00.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) was given a new $135.00 price target on by analysts at Sanford C. Bernstein. They now have an "outperform" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
